Positive Results for New Diabetes Drug - Diabetes India

Diabetes India

61,842 members12,095 posts

Positive Results for New Diabetes Drug

0 Replies

Interest remains high in drugs for diabetes that force glucose out of the bloodstream and into urine: An FDA advisory committee recommend approval of one such agent, canagliflozin, while Eli Lilly and Boehringer- Ingelheim announced favorable results from phase III studies with another agent called empagliflozin.

Drugs in this class inhibit SGLT-2, a sodium glucose transporter molecule, which impels the kidneys to extract and excrete glucose from the bloodstream.

One of the studies tested empagliflozin as monotherapy for patients with type 2 diabetes, while two others evaluated it as an adjunct to other standard drugs including metformin, sulfonylurea agents, and pioglitazone (Actos). The fourth was primarily a safety study in patients with renal impairment.

The studies met their primary efficacy endpoint, the companies said, which was a significant reduction in glycated hemoglobin relative to the placebo groups.

Although the pioneering compound in this class, dapagliflozin, was rejected last year by the FDA, companies still believe that such drugs can be blockbuster products because they reduce blood sugar so directly.

Read more about...

You may also like...

Positive results with Ayurvedic Diabetes Powder

purely as a user: I had purchased an Ayurvedic Diabetes Powder from one of the members of this...

Govt bans popular diabetes drug and analgin

medicines—the widely prescribed anti-diabetes drug pioglitazone, painkiller analgin and...

Kerala Man’s New Jackfruit Flour Helps Control Diabetes, Bags National Award

blood sugar levels and help reverse diabetes. According to a...

Jardiance (new drug)

Jardiance is the only current drug proven to lower blood sugar while reducing CVD by 38%. It lowers

Berberine: The Plant Alkaloid that Treats Diabetes & Digestive Problems

natural remedies for diabetes. During one study, berberine was found to lower blood glucose,...